Could a common bladder drug tame POTS?
NCT ID NCT07585513
First seen May 13, 2026 · Last updated May 25, 2026 · Updated 3 times
Summary
This study tests whether mirabegron, a drug already used for overactive bladder, can reduce symptoms of Postural Orthostatic Tachycardia Syndrome (POTS), a condition that causes a rapid heartbeat upon standing. About 36 adults with confirmed POTS will receive either the drug or a placebo. The main goal is to see if the drug lowers the number of symptom episodes reported each day.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.